These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18401364)

  • 1. FDA to vet embryonic stem cells' safety.
    Baker M
    Nature; 2008 Apr; 452(7188):670. PubMed ID: 18401364
    [No Abstract]   [Full Text] [Related]  

  • 2. Caution urged in trial of stem cells to treat spinal-cord injury.
    Barde Y
    Nature; 2009 Mar; 458(7234):29. PubMed ID: 19262651
    [No Abstract]   [Full Text] [Related]  

  • 3. Treating diseases with adult stem cells.
    Prentice DA; Tarne G
    Science; 2007 Jan; 315(5810):328. PubMed ID: 17234930
    [No Abstract]   [Full Text] [Related]  

  • 4. Getting embryonic stem cell therapy right.
    Nat Med; 2008 May; 14(5):467. PubMed ID: 18463639
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA penalizes trial misconduct.
    Shaffer C
    Nat Biotechnol; 2009 Oct; 27(10):872. PubMed ID: 19816424
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA regulation of stem cell-based products.
    Fink DW
    Science; 2009 Jun; 324(5935):1662-3. PubMed ID: 19556496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress and deficiencies in the registration of clinical trials.
    Wood AJ
    N Engl J Med; 2009 Feb; 360(8):824-30. PubMed ID: 19228628
    [No Abstract]   [Full Text] [Related]  

  • 8. Stem cells ready for prime time.
    Wadman M
    Nature; 2009 Jan; 457(7229):516. PubMed ID: 19177087
    [No Abstract]   [Full Text] [Related]  

  • 9. Trends in government regulation of device research.
    Acharya A
    J Invasive Cardiol; 1993 Mar; 5(2):69-73. PubMed ID: 10148627
    [No Abstract]   [Full Text] [Related]  

  • 10. Closing a loophole in the FDA Amendments Act.
    Turner EH
    Science; 2008 Oct; 322(5898):44-6. PubMed ID: 18832629
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA oversight of cell therapy clinical trials.
    Au P; Hursh DA; Lim A; Moos MC; Oh SS; Schneider BS; Witten CM
    Sci Transl Med; 2012 Aug; 4(149):149fs31. PubMed ID: 22932219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trials on trial.
    Nature; 2008 May; 453(7194):427-8. PubMed ID: 18497763
    [No Abstract]   [Full Text] [Related]  

  • 13. Preparing for an FDA audit.
    Barnes D
    Epilepsy Res Suppl; 1993; 10():245-50. PubMed ID: 8251103
    [No Abstract]   [Full Text] [Related]  

  • 14. New clinical trials policy at FDA.
    Vastag B
    Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety panel backs principle of gene-therapy trials.
    Check E
    Nature; 2002 Dec; 420(6916):595. PubMed ID: 12478252
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-18. PubMed ID: 18345557
    [No Abstract]   [Full Text] [Related]  

  • 18. Moment of reckoning.
    Wadman M
    Nature; 2007 Apr; 446(7138):844-5. PubMed ID: 17443154
    [No Abstract]   [Full Text] [Related]  

  • 19. New law gives FDA more influence to monitor drug safety.
    Wadman M
    Nat Med; 2007 Nov; 13(11):1269. PubMed ID: 17987008
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA should stand firm on stem-cell treatments.
    Nature; 2016 Jul; 535(7610):7-8. PubMed ID: 27383946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.